Income Statement (TTM)
I.M.D. International Medical Devices S.p.A. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 42 | 41 | 41 | 40 | 38 | 39 | 39 | 39 | 40 |
| Change (%) | -9.53 | -0.94 | -0.95 | -3.16 | -3.26 | 0.47 | 0.47 | 1.15 | 1.14 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 33 | 30 | 30 | 30 | 29 | 28 | 28 | 28 | 29 | 29 |
| Change (%) | -9.29 | -0.09 | -0.09 | -3.16 | -3.26 | -0.06 | -0.06 | 2.41 | 2.35 | |
| % of Revenue | 71.63 | 71.81 | 72.43 | 73.06 | 73.07 | 73.07 | 72.69 | 72.31 | 73.21 | 74.09 |
| Gross Operating Profit | 13 | 12 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 10 |
| Change (%) | -10.13 | -3.12 | -3.22 | -3.18 | -3.28 | 1.89 | 1.86 | -2.14 | -2.18 | |
| % of Revenue | 28.37 | 28.19 | 27.57 | 26.94 | 26.93 | 26.93 | 27.31 | 27.69 | 26.79 | 25.91 |
| SG&A | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 |
| Change (%) | 0.38 | 0.19 | 0.19 | 0.35 | 0.35 | 2.38 | 2.33 | 0.77 | 0.77 | |
| % of Revenue | 13.01 | 14.44 | 14.61 | 14.77 | 15.31 | 15.88 | 16.18 | 16.48 | 16.42 | 16.36 |
| R&D | ||||||||||
| Change (%) | ||||||||||
| % of Revenue | ||||||||||
| OpEx | 41 | 37 | 37 | 37 | 36 | 35 | 35 | 35 | 36 | 37 |
| Change (%) | -8.64 | 0.06 | 0.06 | -2.62 | -2.69 | 0.45 | 0.27 | 1.61 | 1.77 | |
| % of Revenue | 87.51 | 88.36 | 89.26 | 90.18 | 90.69 | 91.23 | 91.22 | 91.04 | 91.45 | 92.02 |
| Operating Income | 6 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Change (%) | -15.72 | -8.60 | -9.41 | -8.18 | -8.91 | 0.62 | 2.54 | -3.56 | -5.63 | |
| % of Revenue | 12.49 | 11.64 | 10.74 | 9.82 | 9.31 | 8.77 | 8.78 | 8.96 | 8.55 | 7.98 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 120.64 | 73.57 | 42.39 | 20.47 | 16.99 | -8.95 | -9.83 | -22.33 | -28.75 | |
| % of Revenue | -0.03 | -0.08 | -0.15 | -0.21 | -0.26 | -0.31 | -0.28 | -0.26 | -0.20 | -0.14 |
| Net Income | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
| Change (%) | -28.78 | -10.12 | -11.26 | -2.57 | -2.64 | 8.11 | 7.50 | -6.74 | -7.22 | |
| % of Revenue | 8.89 | 7.00 | 6.35 | 5.69 | 5.73 | 5.76 | 6.20 | 6.63 | 6.12 | 5.61 |
Source: Capital IQ
